i-SENS, Inc. provides diagnostic biosensors in South Korea. The company offers point of care testing devices, such as HbA1c, blood gas, electrolyte, and PT/INR analyzers; CareSens blood glucose monitoring systems; and lancing and other ancillary devices, as well as diabetes management services. It exports its products to approximately 110 countries, including the United States, Japan, and Europe. The company was founded in 2000 and is headquartered in Seoul, South Korea.
Frequently asked questions
What sector does i-SENS Inc (099190) operate in?
i-SENS Inc belongs to the Healthcare sector and operates in the Healthcare Equipment & Supplies industry.
What is i-SENS Inc (099190) current stock price?
As of the latest data, i-SENS Inc stock price is ₩18,270, with a previous close of ₩18,480. i-SENS Inc lost -₩210 in the last trading session, representing a -1.14% loss.
What is i-SENS Inc (099190) current market capitalization?
i-SENS Inc market cap is approximately 250.98 billion.
Does i-SENS Inc (099190) pay dividends?
Yes. i-SENS Inc pays annual dividends with an annualized yield of 0.55% and an estimated annual payout of ₩100 per share.
When is the next ex-dividend date for i-SENS Inc (099190)?
The next ex-dividend date is scheduled for December 29, 2026.
What is i-SENS Inc (099190) beta (volatility) score?
i-SENS Inc has a beta of 0.415, indicating lower volatility than the overall market.